Home/Filings/4/0001209191-20-042615
4//SEC Filing

Thornton Michael Milos 4

Accession 0001209191-20-042615

CIK 0001681682other

Filed

Jul 15, 8:00 PM ET

Accepted

Jul 16, 4:06 PM ET

Size

7.0 KB

Accession

0001209191-20-042615

Insider Transaction Report

Form 4
Period: 2020-07-15
Thornton Michael Milos
Chief Technology Officer
Transactions
  • Exercise of In-Money

    Warrants

    2020-07-1526,00024,252 total
    Exercise: $0.87From: 2019-12-11Exp: 2024-12-11Common Stock (26,000 underlying)
  • Exercise of In-Money

    Common Stock

    2020-07-15$0.87/sh+26,000$22,620293,710 total
Footnotes (1)
  • [F1]Includes unvested restricted stock units.

Issuer

ENDRA Life Sciences Inc.

CIK 0001681682

Entity typeother

Related Parties

1
  • filerCIK 0001706297

Filing Metadata

Form type
4
Filed
Jul 15, 8:00 PM ET
Accepted
Jul 16, 4:06 PM ET
Size
7.0 KB